SCHEMBL10034358

SCHEMBL10034358

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5ccc(-c6ccccc6)cc5)cc4)c4ccc5c(c4)C4(c6ccccc6-c6ccccc64)c4cc(-c6ccc7ccccc7c6)ccc4-5)cc3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 9/20 0.42
ESR1 P03372 3/20 0.37
ESR2 Q92731 3/20 0.37
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
CYP1A1 P04798 1/20 0.35
CYP1B1 Q16678 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
ACMSD Q8TDX5 1/20 0.35
GSTP1 P09211 1/20 0.34
CYP17A1 P05093 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
BACE1 P56817 1/20 0.33
LPL P06858 1/20 0.33
LIPG Q9Y5X9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17243541 0.99 PDK2 (0.41) PDK2ESR1ESR2HSD17B1HSD17B2
SCHEMBL20073103 0.99 PDK2 (0.40) PDK2ESR1ESR2HSD17B1HSD17B2
SCHEMBL23179762 0.97 PDK2 (0.40) PDK2ESR1ESR2HSD17B1HSD17B2
SCHEMBL23179638 0.96 PDK2 (0.38) PDK2ESR1ESR2HSD17B1HSD17B2
SCHEMBL19567760 0.96 PDK2 (0.43) PDK2ESR1ESR2HSD17B1HSD17B2
SCHEMBL13634135 0.96 ESR1 (0.38) PDK2ESR1ESR2HSD17B1HSD17B2
SCHEMBL24647506 0.96 ESR1 (0.38) PDK2ESR1ESR2HSD17B1HSD17B2
SCHEMBL22425475 0.96 ESR1 (0.38) PDK2ESR1ESR2HSD17B1HSD17B2
SCHEMBL17412441 0.96 ESR1 (0.40) PDK2ESR1ESR2HSD17B1HSD17B2
SCHEMBL21392552 0.96 ESR1 (0.40) PDK2ESR1ESR2HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8980442-B2 Aromatic amine derivative and organic electroluminescent element using same MITSUI CHEMICALS, INC. (JP) 2015-03-17 US disclosed
US-20120012832-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME MITSUI CHEMICALS, INC. (JP) 2012-01-19 US disclosed
US-20120012832-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME MITSUI CHEMICALS, INC. (JP) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120012832-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME MAOA, MAOB, TYR PDK2 1940/4885ESR1 213/4885ESR2 685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.